Document Type : Original Article

Authors

1 Department of Medicine, G R Medical College, Gwalior, Madhya Pradesh, India

2 Department of Oncoanesthesia and Palliative Care, AIIMS, New Delhi, India

3 Department of Pulmonary, Critical Care and Sleep Medicine, AIIMS, New Delhi, India

Abstract

BACKGROUND: The world is worsely hit by the COVID‑19 pandemic resulting in increased morbidity 
and mortality. Increased mortality has been observed in older adults with multiple comorbidities. 
Six‑minute walk distance (6MWD) at admission can help us to guide the requirement of oxygen 
during hospital stay that can be used to determine which patient can be managed at home.
MATERIALS AND METHODS: This study was a prospective observational study conducted on 
COVID‑19 patients admitted at AIIMS, New Delhi, from October to December 2020. Patients aged more 
than 60 years were included in the study and underwent 6‑min walk tests. Polypharmacy and multimorbidity 
were also assessed along with dyspnea which was measured on BORG scale. P < 0.05 was considered 
statistically significant. Statistical software STATA (version 14.2) was used for all the analyses.
RESULTS: The mean age of the study population was 68.76 (7.4). Oxygen saturation prior to 
the 6‑MWT was normal and has significantly higher than the post test (P ≤ 0.001). 6MWD was 
significantly correlated with pre values of oxygen saturation. 6MWD was observed more in patients 
who did not require oxygen during hospital stay. Self‑reported dyspnea, pulse rate, oxygen saturation, 
and systolic blood pressure were significantly associated with the patients who had an oxygen 
requirement during the hospital stay.
CONCLUSION: Self‑reported dyspnea after 6MWT was found to be associated with oxygen 
requirement during hospital stay. Patients who have covered more distance in 6‑min walk test have 
less oxygen requirement during hospital stay hence can be managed at home. This will reduce the 
health‑care burden and will help to tackle the outburst during the ongoing pandemic.

Keywords

1. Shreffler J, Petrey J, Huecker M. The impact of COVID‑19 on 
healthcare worker wellness: A scoping review. West J Emerg 
Med 2020;21:1059‑66.
2. Ahmadi MN, Huang BH, Inan‑Eroglu E, Hamer M, Stamatakis E. 
Lifestyle risk factors and infectious disease mortality, including 
COVID‑19, among middle aged and older adults: Evidence from 
a community‑based cohort study in the United Kingdom. Brain 
Behav Immun 2021Apr 30:S0889‑1591(21)00180‑X. doi: 10.1016/j.
bbi.2021.04.022. ePub ahead of print. PMID: 33940153; PMCID: 
PMC8127518.
3. Richardson S, Hirsch JS, Narasimhan M, Crawford JM, McGinn T, 
Davidson KW, et al. Presenting characteristics, comorbidities, and 
outcomes among 5700 patients hospitalized with COVID‑19 in 
the New York City Area. JAMA 2020;323:2052‑9.
4. Sharma G, Goodwin J. Effect of aging on respiratory system 
physiology and immunology. Clin Interv Aging 2006;1:253‑60.
5. Du Bois RM, Albera C, Bradford WZ, Costabel U, Leff JA, 
NobelPW, et al. 6‑Minute walk distance is an independent predictor 
of mortality in patients with idiopathic pulmonary fibrosis. Eur 
Respir J 2014;43(5):1421‑9. [doi: 10.1183/09031936.00131813.] EPub 
2013 Dec 5. PMID: 24311766.
6. Mancuzo EV, Soares MR, Pereira CA. Six‑minute walk distance 
and survival time in patients with idiopathic pulmonary fibrosis 
in Brazil. J Bras Pneumol 2018;44:267‑72.
7. Shojaei A, Salari P. COVID‑19 and the “Stay at home” 
recommendation: An ethnographic study. J Educ Health Promot 
2021;10:62.
8. Dunn A, Marsden DL, Nugent E, Van Vliet P, Spratt NJ, Attia J, et al. Protocol variations and six‑minute walk test performance in 
stroke survivors: A systematic review with meta‑analysis. Stroke 
Res Treat 2015;2015:484813.
9. Brooks D, Solway S. ATS statement on six‑minute walk test. Am 
J Respir Crit Care Med 2003;167:1287.
10. ATS Committee on Proficiency Standards for clinical pulmonary 
function laboratories. ATS statement: Guidelines for the 
six‑minute walk test. Am J Respir Crit Care Med 2002 Jul; 
166(1):111‑7. [doi: 10.1164/ajrccm.166.1.at1102].PMID: 12091180.
11. Chopra S, Ranjan P, Singh V, Kumar S, Arora M, Hasan MS,
et al. Impact of COVID‑19 on lifestyle‑related behaviours – A 
cross‑sectional audit of responses from nine hundred and 
ninety‑five participants from India. Diabetes Metab Syndr 
2020;14:2021‑30.
12. Rahman S, Singh K, Dhingra S, Charan J, Sharma P, Islam S, et al.
The double burden of the COVID‑19 pandemic and polypharmacy 
on geriatric population‑Public health implications. Ther Clin Risk 
Manag 2020;16:1007‑22.
13. Piaggi G, Gambazza S, Guarise R, Piran M. Pulse oximetry oxygen 
saturation during the 6‑min walk test: A limit for stopping the 
test without resuming it. Eur Respir J 2015;46:1222‑3.
14. van Gestel A, Gajic A, Baty F, Brutsche M. Blood pressure 
variability during the 6‑minute walk test in patients with chronic 
obstructive pulmonary disease. European Respiratory Journal 
2016.48:PA3662. [doi: 10.1183/13993003.congress‑2016.pa3662].
15. Fuglebjerg NJ, Jensen TO, Hoyer N, Ryrsø CK, Lindegaard B, 
Harboe ZB. Silent hypoxia in patients with SARS CoV‑2 infection 
before hospital discharge. Int J Infect Dis 2020;99:100‑1.
16. Dajczman E, Wardini R, Kasymjanova G, Préfontaine D, 
Baltzan MA, Wolkove N. Six minute walk distance is a predictor 
of survival in patients with chronic obstructive pulmonary disease 
undergoing pulmonary rehabilitation. Can Respir J 2015;22:225‑9